A detailed history of Telemetry Investments, L.L.C. transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Telemetry Investments, L.L.C. holds 322,500 shares of RIGL stock, worth $4.68 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares
322,500
Previous 200,000 61.25%
Holding current value
$4.68 Million
Previous $236,000 105.08%
% of portfolio
0.76%
Previous 0.3%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.67 - $11.9 $82,075 - $1.46 Million
122,500 Added 61.25%
322,500 $484,000
Q3 2022

Nov 17, 2022

SELL
$1.1 - $12.2 $33,000 - $366,000
-30,000 Reduced 13.04%
200,000 $236,000
Q2 2022

Aug 15, 2022

BUY
$0.67 - $3.19 $63,650 - $303,050
95,000 Added 70.37%
230,000 $260,000
Q1 2022

May 16, 2022

SELL
$2.22 - $3.45 $122,100 - $189,750
-55,000 Reduced 28.95%
135,000 $404,000
Q4 2021

Feb 14, 2022

BUY
$2.36 - $3.57 $159,300 - $240,975
67,500 Added 55.1%
190,000 $504,000
Q3 2021

Nov 15, 2021

BUY
$3.5 - $4.5 $148,750 - $191,250
42,500 Added 53.13%
122,500 $445,000
Q2 2021

Aug 16, 2021

SELL
$3.09 - $4.54 $30,900 - $45,400
-10,000 Reduced 11.11%
80,000 $347,000
Q1 2021

May 17, 2021

SELL
$3.35 - $4.93 $53,630 - $78,924
-16,009 Reduced 15.1%
90,000 $308,000
Q4 2020

Feb 16, 2021

SELL
$2.35 - $3.74 $514,628 - $819,026
-218,991 Reduced 67.38%
106,009 $371,000
Q3 2020

Nov 16, 2020

BUY
$1.78 - $4.13 $177,110 - $410,935
99,500 Added 44.12%
325,000 $780,000
Q4 2019

Feb 14, 2020

SELL
$1.6 - $2.43 $3,200 - $4,860
-2,000 Reduced 0.88%
225,500 $483,000
Q3 2019

Nov 14, 2019

SELL
$1.63 - $2.62 $10,595 - $17,030
-6,500 Reduced 2.78%
227,500 $425,000
Q2 2019

Aug 14, 2019

SELL
$2.02 - $2.61 $133,320 - $172,260
-66,000 Reduced 22.0%
234,000 $611,000
Q1 2019

May 15, 2019

BUY
$2.0 - $2.65 $80,000 - $106,000
40,000 Added 15.38%
300,000 $771,000
Q4 2018

Feb 14, 2019

BUY
$2.08 - $3.36 $289,120 - $467,040
139,000 Added 114.88%
260,000 $598,000
Q3 2018

Nov 14, 2018

SELL
$2.6 - $3.59 $153,400 - $211,810
-59,000 Reduced 32.78%
121,000 $388,000
Q2 2018

Aug 14, 2018

BUY
$2.83 - $4.11 $155,650 - $226,050
55,000 Added 44.0%
180,000 $509,000
Q1 2018

May 15, 2018

SELL
$3.54 - $4.54 $406,746 - $521,646
-114,900 Reduced 47.89%
125,000 $442,000
Q4 2017

Feb 14, 2018

BUY
$3.23 - $4.3 $128,877 - $171,570
39,900 Added 19.95%
239,900 $931,000
Q3 2017

Nov 14, 2017

BUY
$2.18 - $2.57 $436,000 - $513,999
200,000
200,000 $508,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.51B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Telemetry Investments, L.L.C. Portfolio

Follow Telemetry Investments, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Telemetry Investments, L.L.C. with notifications on news.